Warby Parker Inc. (WRBY) 股票分析
医疗保健Warby Parker Inc.
$25.51
+$0.42 (+1.67%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Warby Parker Inc. operates as a retailer and manufacturer of eyewear products, distributing single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses through its physical retail stores and e-commerce platform across the United States and Canada. The company functions within the Healthcare sector, specifically classified under the Medical Instruments & Supplies industry, which encompasses the production and sale of essential medical devices and vision correction tools. This business model has resulted in a market capitalization of $2.61 billion and generated total revenue of $871.91 million over the trailing twelve months, while employing a workforce of 2,275 individuals. These financial figures indicate that Warby Parker has established itself as a significant player in the consumer healthcare space, possessing a substantial asset base and a diversified revenue stream derived from both direct-to-consumer and brick-and-mortar channels.
财务健康
The company reported revenue of $871.91 million for the trailing twelve months, with net income standing at $1.64 million and EBITDA reaching $45.50 million. The substantial disparity between the $871.91 million in revenue and the minimal $1.64 million in net income reveals a cost structure characterized by significant operating expenses that absorb the majority of top-line growth, leaving a net profit margin of only 0.2%. Despite the low net income, the company generated positive free cash flow of $32.60 million, which signifies a degree of financial flexibility that allows management to fund capital expenditures or reduce debt without immediate reliance on external equity financing. The gross margin stands at 54.0%, reflecting a high markup on individual eyewear units, yet the operating margin is negative at -4.5%, indicating that overhead costs, including rent and logistics, currently exceed operating profits before interest and taxes. The profit margin of 0.2% further underscores the challenge of translating gross profitability into bottom-line earnings at this stage of the business lifecycle. Regarding liquidity and leverage, the company holds $286.36 million in cash against $233.15 million in total debt, resulting in a debt-to-equity ratio of 63.40, which suggests a moderately leveraged balance sheet rather than a purely conservative one. However, the current ratio of 2.35 demonstrates strong short-term liquidity, ensuring the company can comfortably meet its immediate obligations with its existing current assets. Return on Equity is recorded at 0.5% and Return on Assets at -0.4%, metrics that collectively reveal limited effectiveness in generating returns relative to the shareholders' equity and the total asset base employed.
估值评估
Warby Parker Inc. trades with a trailing twelve-month P/E ratio of 2130.00 and a forward P/E of 31.54, implying that the market expects earnings to recover significantly and grow rapidly to justify the current multiple. The stark difference between the extremely high trailing P/E and the much lower forward P/E suggests that investors anticipate a dramatic improvement in profitability or a normalization of earnings that will drastically reduce the valuation multiple in the coming years. The price-to-book ratio is 7.09, which indicates that the market is pricing the company at a significant premium over its net book value, likely due to its brand equity and growth potential despite current losses. Alternative valuation metrics such as the price-to-sales ratio of 2.99 and the EV/EBITDA of 56.15 further highlight that the stock is valued on revenue and cash flow generation rather than current net income, a common characteristic for high-growth companies with temporary earnings compression. The stock's 52-week trading range spans from a low of $13.63 to a high of $31.00, providing a clear historical volatility context for recent price movements. The beta value of 2.08 indicates that the stock price is expected to fluctuate with much greater intensity than the broader market, exhibiting nearly double the volatility of a standard equity index.
Growth & Income
The company achieved a revenue growth rate of 11.2% year-over-year, while earnings growth is listed as N/A due to the lack of comparable positive earnings in recent periods to calculate a percentage increase. This divergence implies that the company is prioritizing top-line expansion and market share capture over immediate profitability, a strategy that often precedes a turning point in net income performance. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders, indicating that management intends to reinvest all available free cash flow into business growth, store expansion, or debt reduction. The overall growth and income profile is defined by strong double-digit revenue expansion coupled with a complete absence of dividend income, positioning the asset as a pure-play growth vehicle rather than an income investment vehicle.
同行比较
Warby Parker Inc. (WRBY) 在医疗器械与用品行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Warby Parker Inc. | WRBY | $3.13B | N/A |
| Intuitive Surgical, Inc. | ISRG | $154.64B | 53.2 |
| Becton, Dickinson and Company | BDX | $40.71B | 25.8 |
| Alcon Inc. | ALC | $33.02B | 40.5 |
医疗器械与用品行业平均市盈率为208.0倍。Warby Parker Inc.的市盈率为2551.0。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关医疗器械与用品股票
Intuitive Surgical, Inc.
$154.64B
BDXBecton, Dickinson and Company
$40.71B
ALCAlcon Inc.
$33.02B
MDLNMedline Inc.
$30.58B
RMDResMed Inc.
$30.18B
WSTWest Pharmaceutical Services, Inc.
$22.34B
医疗保健热门股票
Eli Lilly and Company
$949.47B
JNJJohnson & Johnson
$554.09B
ABBVAbbVie Inc.
$376.54B
UNHUnitedHealth Group Incorporated
$342.24B
MRKMerck & Co., Inc.
$302.33B
关于Warby Parker Inc.
Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
公司简介以英文显示。
访问官网 →